Grantham, Mayo, Van Otterloo & Co (GMO)’s Camden National CAC Stock Holding History
Bought
Maintained
Sold
Other funds holding CAC
BCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CAC Position: Q1 2023 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Camden National (CAC) in Q1 2023, closing a stake of 5,172 shares — an estimated $216K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CAC in Q1 2019 and held it in 14 quarters. The position peaked at $5.7M in Q2 2019. 127 funds tracked by Wall St. Rank hold CAC as of Q1 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Camden National position as of Q1 2023 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,172 Camden National shares in Q1 2023, an estimated $216K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Camden National in Q1 2019 and held it in 14 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Camden National position peaked at $5.7M in Q2 2019.
- 127 funds tracked by Wall St. Rank held Camden National as of Q1 2023.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.